A RNAi-based Therapeutic Proof of Concept Targets Salmonid Whirling Disease in Vivo

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Jun 3

PMID 28575083

Citations 7

Authors

Subhodeep Sarker

Simon Menanteau-Ledouble

Mohamed H Kotob

Mansour El-Matbouli

Affiliations

Soon will be listed here.

Abstract

Myxobolus cerebralis is a cnidarian-myxozoan parasite that causes salmonid whirling disease. M. cerebralis alternates between two hosts: (1) a vertebrate salmonid and (2) an invertebrate oligochaete, Tubifex tubifex. There is no successful treatment for salmonid whirling disease. MyxSP-1 is a M. cerebralis serine protease implicated in whirling disease pathogenesis. We hypothesized that short-interfering RNA (siRNA)-induced RNA interference (RNAi) can silence MyxSP-1 in the invertebrate host and abrogate the M. cerebralis life cycle. This would preclude whirling disease infection in the salmonid host. To test this hypothesis, we first developed a siRNA delivery protocol in T. tubifex. Second, we determined the effective dose for siRNA treatment of M. cerebralis-infected T. tubifex. M. cerebralis-infected T. tubifex were treated with different concentrations of MyxSP-1 or negative control siRNAs (1μM, 2μM, 5μM or 7μM) at 15°C for 24h, 48h, 72h and 96h, respectively. We monitored MyxSP-1 knockdown using real-time quantitative PCR (qPCR). siRNA treatment with MyxSP-1 siRNA at 2μM concentration for 24h at 15°C showed maximum significant MyxSP-1 knockdown in T. tubifex. Third, we determined the time points in the M. cerebralis life cycle in T. tubifex at which siRNA treatment was most effective. M. cerebralis-infected T. tubifex were treated with MyxSP-1 or negative control siRNAs (2μM concentration for 24h at 15°C) at 24 hours post-infection (24hpi), 48hpi, 72hpi, 96hpi, 1 month post-infection (1mpi), 2mpi and 3mpi, respectively. We observed that siRNA treatment of T. tubifex was most effective at 1mpi, 2mpi and 3mpi. Fourth, we immersed specific-pathogen-free rainbow trout fry in water inhabited by MyxSP-1 siRNA-treated T. tubifex (at 1mpi, 2mpi and 3mpi). The salmonids did not develop whirling disease and showed significant MyxSP-1 knockdown. We also observed long-term RNAi in T. tubifex. Together these results demonstrate a novel RNAi-based therapeutic proof of concept in vivo against salmonid whirling disease.

Citing Articles

RNAi-directed knockdown in the cnidarian fish blood parasite Sphaerospora molnari.

Kyslik J, Born-Torrijos A, Holzer A, Kosakyan A Sci Rep. 2024; 14(1):3545.

PMID: 38347054 PMC: 10861503. DOI: 10.1038/s41598-024-54171-0.

The Immune Response to the Myxozoan Parasite in Salmonids: A Review on Whirling Disease.

Akram N, El-Matbouli M, Saleh M Int J Mol Sci. 2023; 24(24).

PMID: 38139218 PMC: 10743445. DOI: 10.3390/ijms242417392.

Review: Recent Applications of Gene Editing in Fish Species and Aquatic Medicine.

Gutasi A, Hammer S, El-Matbouli M, Saleh M Animals (Basel). 2023; 13(7).

PMID: 37048506 PMC: 10093118. DOI: 10.3390/ani13071250.

Silencing of heat shock protein 90 (hsp90): Effect on development and infectivity of Ichthyophthirius multifiliis.

Saleh M, Abdel-Baki A, Dkhil M, El-Matbouli M, Al-Quraishy S BMC Vet Res. 2023; 19(1):62.

PMID: 36932404 PMC: 10024447. DOI: 10.1186/s12917-023-03613-4.

Selection of suitable reference genes for gene expression studies in myxosporean (Myxozoa, Cnidaria) parasites.

Kosakyan A, Alama-Bermejo G, Bartosova-Sojkova P, Born-Torrijos A, Sima R, Nenarokova A Sci Rep. 2019; 9(1):15073.

PMID: 31636316 PMC: 6803631. DOI: 10.1038/s41598-019-51479-0.

References

Schyth B, Lorenzen N, Pedersen F . A high throughput in vivo model for testing delivery and antiviral effects of siRNAs in vertebrates. Mol Ther. 2007; 15(7):1366-72. DOI: 10.1038/sj.mt.6300150. View

Bobbin M, Rossi J . RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?. Annu Rev Pharmacol Toxicol. 2016; 56:103-22. DOI: 10.1146/annurev-pharmtox-010715-103633. View

Fire A, Xu S, Montgomery M, Kostas S, Driver S, Mello C . Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998; 391(6669):806-11. DOI: 10.1038/35888. View

Fetherman E, Winkelman D, Baerwald M, Schisler G . Survival and reproduction of Myxobolus cerebralis-resistant rainbow trout introduced to the Colorado river and increased resistance of age-0 progeny. PLoS One. 2014; 9(5):e96954. PMC: 4014575. DOI: 10.1371/journal.pone.0096954. View

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. PMC: 126239. DOI: 10.1186/gb-2002-3-7-research0034. View

Naito Y, Yoshimura J, Morishita S, Ui-Tei K . siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect. BMC Bioinformatics. 2009; 10:392. PMC: 2791777. DOI: 10.1186/1471-2105-10-392. View

Beauchamp K, Kathman R, McDowell T, Hedrick R . Molecular phylogeny of tubificid oligochaetes with special emphasis on Tubifex tubifex (Tubificidae). Mol Phylogenet Evol. 2001; 19(2):216-24. DOI: 10.1006/mpev.2001.0923. View

Kelley G, Zagmutt-Vergara F, Leutenegger C, Adkison M, Baxa D, Hedrick R . Identification of a serine protease gene expressed by Myxobolus cerebralis during development in rainbow trout Oncorhynchus mykiss. Dis Aquat Organ. 2004; 59(3):235-48. DOI: 10.3354/dao059235. View

Dadara A, Skelly P . Gene suppression in schistosomes using RNAi. Methods Mol Biol. 2014; 1201:143-64. DOI: 10.1007/978-1-4939-1438-8_8. View

10.

El-Matbouli M, Hoffmann R, Schoel H, McDowell T, Hedrick R . Whirling disease: host specificity and interaction between the actinosporean stage of Myxobolus cerebralis and rainbow trout Oncorhynchus mykiss. Dis Aquat Organ. 1999; 35(1):1-12. DOI: 10.3354/dao035001. View

11.

Baerwald M . Temporal expression patterns of rainbow trout immune-related genes in response to Myxobolus cerebralis exposure. Fish Shellfish Immunol. 2013; 35(3):965-71. DOI: 10.1016/j.fsi.2013.07.008. View

12.

Sarker S, El-Matbouli M . Can RNAi Target Salmonid Whirling Disease In Vivo?. Nucleic Acid Ther. 2015; 25(5):285-6. DOI: 10.1089/nat.2015.0549. View

13.

Baerwald M, Welsh A, Hedrick R, May B . Discovery of genes implicated in whirling disease infection and resistance in rainbow trout using genome-wide expression profiling. BMC Genomics. 2008; 9:37. PMC: 2257940. DOI: 10.1186/1471-2164-9-37. View

14.

Beauchamp K, Gay M, Kelley G, El-Matbouli M, Kathman R, Nehring R . Prevalence and susceptibility of infection to Myxobolus cerebralis, and genetic differences among populations of Tubifex tubifex. Dis Aquat Organ. 2002; 51(2):113-21. DOI: 10.3354/dao051113. View

15.

Baerwald M, Petersen J, Hedrick R, Schisler G, May B . A major effect quantitative trait locus for whirling disease resistance identified in rainbow trout (Oncorhynchus mykiss). Heredity (Edinb). 2010; 106(6):920-6. PMC: 3186244. DOI: 10.1038/hdy.2010.137. View

16.

Hedrick R, McDowell T, Marty G, Fosgate G, Mukkatira K, Myklebust K . Susceptibility of two strains of rainbow trout (one with suspected resistance to whirling disease) to Myxobolus cerebralis infection. Dis Aquat Organ. 2003; 55(1):37-44. DOI: 10.3354/dao055037. View

17.

Fetherman E, Winkelman D, Schisler G, Antolin M . Genetic basis of differences in myxospore count between whirling disease-resistant and susceptible strains of rainbow trout. Dis Aquat Organ. 2012; 102(2):97-106. DOI: 10.3354/dao02543. View

18.

El-Matbouli M, Hoffmann R . Light and electron microscopic studies on the chronological development of Myxobolus cerebralis to the actinosporean stage in Tubifex tubifex. Int J Parasitol. 1998; 28(1):195-217. DOI: 10.1016/s0020-7519(97)00176-8. View

19.

Hedrick R, McDowell T, Marty G, Mukkatira K, Antonio D, Andree K . Ultraviolet irradiation inactivates the waterborne infective stages of Myxobolus cerebralis: a treatment for hatchery water supplies. Dis Aquat Organ. 2000; 42(1):53-9. DOI: 10.3354/dao042053. View

20.

Hedrick R, El-Matbouli M, Adkison M, MacConnell E . Whirling disease: re-emergence among wild trout. Immunol Rev. 1999; 166:365-76. DOI: 10.1111/j.1600-065x.1998.tb01276.x. View